Key facts
- This page summarizes Paula H. Cholmondeley's Form 4 filing for Lexeo Therapeutics, Inc. (LXEO).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 26 Nov 2024, 17:00.
Paula H. Cholmondeley - 25 Nov 2024 Form 4 Insider Report for Lexeo Therapeutics, Inc. (LXEO)
- Reporting relationship
- Director
- Issuer ticker
- LXEO
- Reported as of
- 25 Nov 2024
- Net transaction value
- +$104,852
- SEC form
- 4
- Accepted by SEC
- 26 Nov 2024, 17:00:06 UTC
- Prior SEC filing
- 27 Jun 2024
- Next SEC filing
- 30 Jun 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Youjin Choi, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Paula H. Cholmondeley filed Form 4 for Lexeo Therapeutics, Inc. (LXEO) on 26 Nov 2024.
Change
- Previous filing in this sequence was filed on 27 Jun 2024.
- Current net transaction value: +$104,852.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LXEO
transaction
Common Stock
Purchase
- Transaction value
- $104,852
- Shares
- +15,000
- Change %
- +96%
- Price
- $6.99
- Shares after
- 30,627
- Date
- 25 Nov 2024
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
15,627 of the shares are subject to vesting and vest at the following rate: 1/48th of the shares vested or vest in monthly installments commencing on December 1, 2021, subject to the Reporting Person's continuous service.